Oxaliplatin News and Research

RSS
Study suggests revolutionary way to make cancer cells more susceptible to existing chemotherapies

Study suggests revolutionary way to make cancer cells more susceptible to existing chemotherapies

IQWiG finds colorectal cancer drug combination has added benefit only for some patients

IQWiG finds colorectal cancer drug combination has added benefit only for some patients

Novel therapy offers hope for effective treatment of intractable metastatic cancers

Novel therapy offers hope for effective treatment of intractable metastatic cancers

Study shows microRNA molecule prevents cancer cells from responding to chemotherapy treatment

Study shows microRNA molecule prevents cancer cells from responding to chemotherapy treatment

TAILOR study shows treatment with Erbitux plus FOLFOX improves survival in RAS wild-type mCRC patients

TAILOR study shows treatment with Erbitux plus FOLFOX improves survival in RAS wild-type mCRC patients

Chemoradiotherapy and post-operative chemotherapy provide similar outcomes in gastric cancer patients

Chemoradiotherapy and post-operative chemotherapy provide similar outcomes in gastric cancer patients

Novel anti-interleukin 1-alpha antibody shows promise in treating advanced colorectal cancer patients

Novel anti-interleukin 1-alpha antibody shows promise in treating advanced colorectal cancer patients

Bayer-new phase 3 liver cancer data

Bayer-new phase 3 liver cancer data

Study shows high cost, high side effects and little gain for chemotherapy in older mCRC patients

Study shows high cost, high side effects and little gain for chemotherapy in older mCRC patients

Gene expression analysis points metastatic CRC patient to successful irbesartan therapy

Gene expression analysis points metastatic CRC patient to successful irbesartan therapy

Adjuvant Chemotherapy Colon Cancer Trials Should ‘Stratify By MSI, KRAS, BRAF’

Adjuvant Chemotherapy Colon Cancer Trials Should ‘Stratify By MSI, KRAS, BRAF’

NUS-led study discovers potential therapeutic approach against colorectal cancer

NUS-led study discovers potential therapeutic approach against colorectal cancer

New clinical trial uses aggressive treatment method for patients with pancreas cancer

New clinical trial uses aggressive treatment method for patients with pancreas cancer

DelMar reports positive data from preclinical study of VAL-083 for treatment of ovarian cancer

DelMar reports positive data from preclinical study of VAL-083 for treatment of ovarian cancer

FDA approves LONSURF for treatment of patients with metastatic colorectal cancer

FDA approves LONSURF for treatment of patients with metastatic colorectal cancer

Ups and downs of incorporating new treatment to reduce oxaliplatin-induced neuropathy

Ups and downs of incorporating new treatment to reduce oxaliplatin-induced neuropathy

Hutchison MediPharma achieves primary endpoint in POC Phase II study to treat NSCLC patients

Hutchison MediPharma achieves primary endpoint in POC Phase II study to treat NSCLC patients

SENRI Trial: NK1 antagonists may prevent emesis in patients treated with oxaliplatin-based chemotherapy

SENRI Trial: NK1 antagonists may prevent emesis in patients treated with oxaliplatin-based chemotherapy

The Lancet Oncology publishes results of CYRAMZA (ramucirumab) Phase III trial for HCC treatment

The Lancet Oncology publishes results of CYRAMZA (ramucirumab) Phase III trial for HCC treatment

Phase 3 study shows Vectibix meets primary endpoint in patients with chemorefractory wild-type KRAS mCRC

Phase 3 study shows Vectibix meets primary endpoint in patients with chemorefractory wild-type KRAS mCRC